208 related articles for article (PubMed ID: 2494115)
1. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.
Desai SD; Birdi TJ; Antia NH
Infect Immun; 1989 Apr; 57(4):1311-7. PubMed ID: 2494115
[TBL] [Abstract][Full Text] [Related]
2. An antigenic complex that restores ability in leprosy patients to kill Mycobacterium leprae--the probable molecular events identified by in vitro experiments.
Mahadevan PR; Robinson P
Trop Med Parasitol; 1990 Sep; 41(3):310-3. PubMed ID: 2255852
[TBL] [Abstract][Full Text] [Related]
3. An analysis of in vitro T cell responsiveness in lepromatous leprosy.
Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA
J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
6. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
[TBL] [Abstract][Full Text] [Related]
7. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
8. Delipidified cell components of Mycobacterium leprae and its applications.
Mahadevan PR; Robinson P; Vermani M; Pardhy A; Joshi S
Indian J Lepr; 1991; 63(3-4):371-87. PubMed ID: 1804891
[TBL] [Abstract][Full Text] [Related]
9. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
10. Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.
Nogueira N; Kaplan G; Levy E; Sarno EN; Kushner P; Granelli-Piperno A; Vieira L; Colomer Gould V; Levis W; Steinman R
J Exp Med; 1983 Dec; 158(6):2165-70. PubMed ID: 6417263
[TBL] [Abstract][Full Text] [Related]
11. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
[TBL] [Abstract][Full Text] [Related]
12. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
13. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
14. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.
García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA
J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444
[TBL] [Abstract][Full Text] [Related]
15. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
[TBL] [Abstract][Full Text] [Related]
16. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
[TBL] [Abstract][Full Text] [Related]
17. HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells.
Mutis T; De Bueger M; Bakker A; Ottenhoff TH
Scand J Immunol; 1993 Jan; 37(1):43-51. PubMed ID: 8418472
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages.
Hagge DA; Ray NA; Krahenbuhl JL; Adams LB
J Immunol; 2004 Jun; 172(12):7771-9. PubMed ID: 15187161
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium leprae-burdened macrophages are refractory to activation by gamma interferon.
Sibley LD; Krahenbuhl JL
Infect Immun; 1987 Feb; 55(2):446-50. PubMed ID: 3100449
[TBL] [Abstract][Full Text] [Related]
20. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
Sasiain MD; de la Barrera S; Valdez R; Balina LM
Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]